On June 27th, Gelunhui reported that Zhengguang Group fell more than 7%, and Goldcard Hi-Tech, Xinjiang Bai Hua Cun Pharma Tech, HYBIO Pharmaceutical, Gan & Lee Pharmaceuticals followed the decline.
A股减肥药概念震荡走低 争光股份跌超7%
A-shares weight loss drugs concept fluctuates and falls, Zhenguang shares drop more than 7%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.